| |
|
|
|
|
|
|
|||
|
Blood, 17 September 2009, Vol. 114, No. 12, pp. 2497-2505. Prepublished online as a Blood First Edition Paper on July 16, 2009; DOI 10.1182/blood-2009-02-204925.
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice1 Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY; and Departments of 2 Pediatrics and 3 Pathology, Carver College of Medicine, University of Iowa, Iowa City
The mouse Lupo (I282N) mutation in proline-serine-threonine phosphatase–interacting protein 2 (PSTPIP2) leads to reduced expression of PSTPIP2 that is associated with a macrophage-mediated autoinflammatory disease. Another mutation in PSTPIP2, L98P, termed chronic multifocal osteomyelits (cmo), leads to a disease in mice that resembles chronic recurrent multifocal osteomyelits in humans. The cellular basis of cmo disease was investigated. cmo disease develops independently of lymphocytes and is cured by bone marrow transplantation. Macrophages, mast cells, and osteoclasts from cmo mice fail to express detectable PSTPIP2 protein. Asymptomatic Pstpip2cmo/cmo mice have increased circulating levels of macrophage inflammatory protein 1-
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||